Triple-combo of drugs targeting pancreatic cancer looks to human trials
Impressive new preclinical work from a team at MIT has found a combination of three experimental immunotherapy drugs could help shrink, or even eliminate, pancreatic tumors. Each of the three drugs have demonstrated safety in early-stage human trials a… Continue reading Triple-combo of drugs targeting pancreatic cancer looks to human trials